Fundraising Fox
Fountain Therapeutics
San Francisco, US · Founded 2018 · Delaware corporation · 4 employees on LinkedIn · 5 known investors
Find your way into Fountain Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask William Greene to introduce you to Tom Cheung
You →William · together at Fountain Therapeutics →Tom
Sign up to find every way you can get introduced to Fountain Therapeutics
- Your email: who you already know at Fountain Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fountain Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.
Founders & leadership
Fountain Therapeutics was founded in 2018 by Thomas Rando, Joseph Rodgers, and Tom Cheung.
Investors · 5
How we know: globenewswire.com · Not right? Tell us
How we know: funding news · globenewswire.com · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$26.9M disclosed across 3 rounds · 2018–2021
▶$15.9MraisedDec 2021 · 8 investors · BiotechnologyRule 506(b)
- William GreeneExecutive Officer, Director
- Thomas RandoExecutive Officer, Director
- Ashish KhannaDirector
- Alex MorganDirector
- Offering amount
- $15.9M
- Amount sold
- $15.9M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6MraisedFeb 2020 · 2 investors · BiotechnologyRule 506(b)
- Ashish KhannaDirector
- Thomas RandoExecutive Officer, Director
- John DimosExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5MraisedSep 2018 · 2 investors · BiotechnologyRule 506(b)
- Thomas A. RandoExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Fountain Therapeutics.
Frequently asked questions
- What does Fountain Therapeutics do?
- Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.
- Who founded Fountain Therapeutics?
- Fountain Therapeutics was founded by Thomas Rando, Joseph Rodgers, Tom Cheung in 2018.
- Who are Fountain Therapeutics's investors?
- Fountain Therapeutics's investors include Alexandria, Khosla Ventures, Nan Fung Life Sciences, R42 Group.
- How much funding has Fountain Therapeutics raised?
- Fountain Therapeutics has disclosed $26.9M raised across 3 rounds.
- Where is Fountain Therapeutics headquartered?
- Fountain Therapeutics is headquartered in San Francisco, US.